Article info

Download PDFPDF

Response to: ‘High dosage of Methylprednisolone as a rescue, second-line treatment in COVID-19 patients who failed to respond to Tocilizumab’ by Conticini et al
Free

Authors

  1. Correspondence to Dr Sofia Ramiro, Department of Rheumatology Zuyderland Medical Center, Heerlen, Limburg 6419, The Netherlands; sofiaramiro{at}gmail.com
View Full Text

Citation

Ramiro S, Mostard R, Landewé RB
Response to: ‘High dosage of Methylprednisolone as a rescue, second-line treatment in COVID-19 patients who failed to respond to Tocilizumab’ by Conticini et al

Publication history

  • Received August 7, 2020
  • Revised August 10, 2020
  • Accepted August 11, 2020
  • First published August 19, 2020.
Online issue publication 
September 12, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.